Table 2 Home insulin use versus no home insulin
From: Insulin use in Type 2 diabetic patients: a predictive of mortality in covid‑19 infection
Home insulin N = 227 | No home insulin N = 469 | p value | |
|---|---|---|---|
ACE inhibitor/ARB | 113 (50%) | 197 (42%) | 0.053 |
Hypertension | 169 (74%) | 312 (67%) | 0.034 |
Hb A1c > 8.1% | 161 (71%) | 205 (44%) | < 0.001 |
D-dimer | 991 [383–3371] | 724 [313–2909] | 0.092 |
Procalcitonin | 0.41 [ 0.16–1.42] | 0.3 [0.11–0.95] | 0.016 |
Acute kidney injury | 119 (52%) | 179 (38%) | < 0.001 |
Pulmonary embolism | 9 (4%) | 28 (6%) | 0.269 |
Intubation | 58 (26%) | 110 (24%) | 0.545 |
Length of hospital stay, days | 8 (4–14) | 8 [4–14.5] | 0.22 |
Death | 33 (15%) | 53 (11%) | 0.224 |